NEW YORK (Feb. 25, 2011) — Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness — but the view it presents is one that is blurred in fascinating …
NEW YORK (Feb. 10, 2011) — A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control d…
NEW YORK, CAMBRIDGE, Mass., AND BOSTON (Feb. 9, 2011) — For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of t…
LA JOLLA, CA — January 4, 2011 — Researchers from The Scripps Research Institute, Weill Cornell Medical College, and Cornell University have produced a long-lasting anti-cocaine immunity in mice by giving them a unique vaccine that combines bi…
NEW YORK (Jan. 4, 2011) — Researchers have produced a lasting anti-cocaine immunity in mice by giving them a safe vaccine that combines bits of the common cold virus with a particle that mimics cocaine.
In their study, published Jan. 4 …
NEW YORK (Dec. 30, 2010) — The brain under general anesthesia isn’t “asleep” as surgery patients are often told — it is placed into a state that is a reversible coma, according to three neuroscientists who have published an extensive review of …
NEW YORK (Nov. 3, 2010) — Scientists at Weill Cornell Medical College have taken an important step toward a better understanding of prostate cancer by uncovering evidence that it is not one disease, as previously believed, but rather several factors…
NEW YORK (Nov. 3, 2010) — Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin’s lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a c…
NEW YORK (November 2, 2010) — For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C — specific protease inhibitor called telaprevir to the current standard therapy mar…
NEW YORK (Oct. 28, 2010) — Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine available. The a…
New York, NY, September 9, 2010 — The use of stem cells for research and their possible application in the treatment of disease are hotly debated topics. In a special issue of Translational Research published this month an international group of m…
The widespread use of a simplified clinical tool to estimate future coronary risk could lead to the classification of millions of Americans into different risk groups than when using the original, “gold-standard” tool. Millions of patients may ha…
